Story Poster
Notre Dame Football Recruiting

2025 QB Stone Saunders One To Watch

January 22, 2022
2,795

Stone Saunders‍ went to the National Underclassmen Combine in San Antonio earlier this month looking to see where he stacks up against the competition and despite being younger than most of the other prospects, the 2025 Pennsylvania quarterback certainly looked like he belonged.

The 6-foot-2, 195-pounder has an impressive early offer sheet.

“I've got offers from Michigan, Pitt, Kent State and Maryland,” the Bishop McDevitt standout said. “It's a really good feeling, but I know that I've still got to work to get better or they're going to go away.

“I've had some interest from Penn State, Old Dominion, Oklahoma State. And I think my coach has told me a couple others as well.”

Notre Dame is recruiting a teammate of Saunders, having already extended an offer to 2023 running back Marquese Williams.

“Hopefully I can hear from them soon,” Saunders said. “I go to a Catholic school right now and they're also a Catholic school, so that would be cool to translate. They're also a good football team.

“They've been to the College Football Playoff multiple times and I want to go to a school that wins.”

Saunders showed the ability to perform in different circumstances this past fall.

“I think I throw good under pressure,” he said. “My line struggled a little bit in the beginning of the season, but we got way better at the end of the season, we did great. I threw pretty good in the beginning of the season under pressure and my deep ball is actually is pretty good also.

It’s early, but he has an idea of what he’s looking for in a college.

“I want to win obviously because we won in high school. We made it to state championship. We didn't win that game, but we're going to get back there. I want to win in college and I want to be somewhere that I can go to the NFL from.”

 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.